Drug intelligence / Profile preview

CCB-005

Development stage: Unknown
Lead developer: Castle Creek Biosciences

Overview

Information regarding the specific pharmaceutical drug "CCB-005" is not readily available in public databases. While the code name "CCB-005" appears in some contexts related to drug targets and indications, there is insufficient specific information to provide a detailed description, mechanism of action, or primary indication for a unique drug entity. The term "CCB-005" also appears in unrelated contexts, such as a form number for a cannabis compliance board, further contributing to the ambiguity.

Targets

COL1A1 (Collagen type I alpha 1 chain)

Beyond the preview

Go deeper on CCB-005.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCB-005.

Explore the full profile